Trial Profile
Relative Bioavailability of a Prasugrel Paediatric Orally Disintegrating Tablet Formulation Compared to the Tablet in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Prasugrel (Primary)
- Indications Acute coronary syndromes; Myocardial infarction; Thrombosis
- Focus Pharmacokinetics
- 14 Oct 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
- 14 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.